Unpacking the GLP-1 Gold Rush
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read

False
June 30, 2025
We ask experts for their views on the GLP-1 market in this exclusive eBook.
1 min read
June 30, 2025
We sit down with Audrey Greenberg to discuss investment, cell therapy, and what to look for when hiring talent.
6 min read
June 27, 2025
Researchers have developed a new way to create covalent peptide inhibitors of transcription factors – proteins once considered “undruggable.”
8 min read
June 27, 2025
Vaccines, mRNA, ADCS, and beyond! Check out our latest eBook where we speak with experts about the trends and challenges in biopharma drug development.
1 min read
June 26, 2025
A look at how nut-derived pharmaceutical ingredients can deliver a sustainable, natural supply of peptides and more.
2 min read
June 26, 2025
Our latest news roundup reports on the Bayer-Tsinghua partnership expansion, GLP-1 diabetes treatments, and GSK EU acceptance of linerixibat.
3 min read
June 25, 2025
Why spray-drying could reduce supply chain costs, address infrastructure challenges, and pave the way for intranasal mRNA vaccine delivery.
5 min read
June 25, 2025
Learning more about the people behind the Power List 2025.
5 min read
June 24, 2025
Our latest news roundup reports on Eli Lilly’s Verve takeover, novel CRISPR delivery research, a growing interest in CD5-based immunotherapy, and more
3 min read
June 24, 2025
Researchers explore how ocular gene delivery strategies for diabetic retinopathy could be improved using nanotechnology.
3 min read
False
False
False